Factors influencing tumour relapse after total laryngectomy

B-ENT

Volumn 1, Issue 1, 2005, Pages 1-10

  Nikolaou, Angelos ^a   Markou, K ^a   Petridis, D ^a   Vlachtsis, K ^a   Nalbantian, M ^a   Daniilidis, I ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Laryngeal carcinoma; Total laryngectomy; Tumour relapse

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PROGNOSIS; RELAPSE; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; DISEASE FREE SURVIVAL; LARYNX TUMOR; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; SURVIVAL; TIME; TRACHEOTOMY;

DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRACHEOTOMY;

EID: 24044515296     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tucker HM. The Larynx. 2nd ed. Thieme Medical Publishers Inc. New-York; 1993:287-324.
2. Hussey DH, Latourette HB, Panje WR. Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa. Ann Otol Rhinol Laryngol. 1991;100(suppl 152):2-16.
3. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet J. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: a 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106:364-369.
4. Sessions DG, Lenox J, Spector GJ, et al. Management of T3N0M0 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2002;112:1281-1288.
5. Gordon G, Vokes E. The role of chemotherapy in head and neck cancer. In: Pensak M. ed. Controversies in Otolaryngology. Thieme Medical Publishers Inc. New York; 2001:34-38.
6. Strome SE, Weinman EC. Advanced larynx cancer. Curr Treat Options Oncol. 2002;3:11-20.
7. Bryant GP, Poulsen MG, Tripcony L, Dickie GJ. Treatment decisions in T3N0M0 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:285-293.
8. Warren S, Gates O. Multiple primary malignant tumours:a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358-1414.
9. Spector GJ, Ogura JH. Tumours of the larynx and laryngopharynx. In: Ballanger JJ ed. Diseases of the nose, throat, ear, head and neck. 13th ed. Lea and Febiger. Philadelphia; 1985:549-602.
10. Miyahara H, Yane K, Tsuruta Y, Uemura H. A clinical study of 213 patients with laryngeal cancer. Nippon Jibiinkoka Gakkai Kaiho. 2002;105:790-798.
11. Kurtulmaz SY, Erkal HS, Serin M, Elhan AH, Cakmak A. Squamous cell carcinomas of the head and neck: descriptive analysis of 1293 cases. J Laryngol Otol. 1997;111:531-535.
12. Makitie A, Pukander J, Raitiola H, et al. Changing trends in the occurrence and subsite distribution of laryngeal cancer in Finland. Eur Arch Otorhinolaryngol. 1999;256:277-279.
13. Krecicki T, Zalesska-Krecicka M, Jagas M, Szajowski K, Rak J. Laryngeal cancer in Lower Silesia: descriptive analysis of 501 cases. Oral Oncol. 1998;34:377-380.
14. Jorgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx-treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol. 2002;41:69-76.
15. Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys. 2002;53:948-958.
16. Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 2002;63:257-267.
17. Pulkkinen JO, Klemi P, Martikainen P, Grenman R. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res. 1999;19:703-707.
18. Wiernik G, Millard PR, Haybittle JL. The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 1991;19:411-417.
19. Jin YT, Kayser S, Kemp BL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bel-2 in laryngeal squamous cell carcinoma. Cancer. 1998;82:2159-2165.
20. Stell PM. Prognosis in laryngeal carcinoma:tumour factors. Clin Otolaryngol. 1990;15:69-81.
21. Moe K, Wolf GT, Fisher SG, Hong WK. Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 1996;122:644-648.
22. Lundgren JA, Gilbert RW, van Nostrand AW, Harwood AR, Keane TJ, Briant TDR. T3N0M0 glottic carcinoma-a failure analysis. Clin Otolaryngol. 1988;13:455-465.
23. Lassaletta L, Garcia-Pallares M, Morera E, Bernaldez R, Gavilan J. T3 glottic cancer: oncologic results and prognostic factors. Otolaryngol Head Neck Surg. 2001;124:556-560.
24. Nikolaou AC, Markou CD, Petridis DG, Daniilidis IC. Second primary neoplasms in patients with laryngeal carcinoma. Laryngoscope. 2000;110:58-64.
25. Ritoe SC, Krabbe PF, Jansen MM, et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope. 2002;112:2002-2008.